List of Tables
    Table 1. Anti Obesity Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Anti Obesity Drugs Market Trends
    Table 3. Anti Obesity Drugs Market Drivers
    Table 4. Anti Obesity Drugs Market Challenges
    Table 5. Anti Obesity Drugs Market Restraints
    Table 6. Global Anti Obesity Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti Obesity Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti Obesity Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti Obesity Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti Obesity Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti Obesity Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Anti Obesity Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Anti Obesity Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Anti Obesity Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Anti Obesity Drugs Price by Manufacturer (2017-2022) & (USD/Units)
    Table 16. Global Anti Obesity Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anti Obesity Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Obesity Drugs as of 2021)
    Table 18. Top Players of Anti Obesity Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Anti Obesity Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Anti Obesity Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Anti Obesity Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Anti Obesity Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Anti Obesity Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Anti Obesity Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Anti Obesity Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Anti Obesity Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Anti Obesity Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Anti Obesity Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Anti Obesity Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Anti Obesity Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Anti Obesity Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Anti Obesity Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Anti Obesity Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Anti Obesity Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Anti Obesity Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Anti Obesity Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Anti Obesity Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Anti Obesity Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Anti Obesity Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Anti Obesity Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Corporation Information
    Table 43. Pfizer Description and Business Overview
    Table 44. Pfizer Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 45. Pfizer Anti Obesity Drugs Product
    Table 46. Pfizer Recent Development
    Table 47. Merck Corporation Information
    Table 48. Merck Description and Business Overview
    Table 49. Merck Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 50. Merck Product
    Table 51. Merck Recent Development
    Table 52. Roche Corporation Information
    Table 53. Roche Description and Business Overview
    Table 54. Roche Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 55. Roche Product
    Table 56. Roche Recent Development
    Table 57. GlaxoSmithKline Corporation Information
    Table 58. GlaxoSmithKline Description and Business Overview
    Table 59. GlaxoSmithKline Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 60. GlaxoSmithKline Product
    Table 61. GlaxoSmithKline Recent Development
    Table 62. AstraZeneca Corporation Information
    Table 63. AstraZeneca Description and Business Overview
    Table 64. AstraZeneca Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 65. AstraZeneca Product
    Table 66. AstraZeneca Recent Development
    Table 67. Boehringer Ingelheim Corporation Information
    Table 68. Boehringer Ingelheim Description and Business Overview
    Table 69. Boehringer Ingelheim Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 70. Boehringer Ingelheim Product
    Table 71. Boehringer Ingelheim Recent Development
    Table 72. Novo Nordisk Corporation Information
    Table 73. Novo Nordisk Description and Business Overview
    Table 74. Novo Nordisk Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 75. Novo Nordisk Product
    Table 76. Novo Nordisk Recent Development
    Table 77. Eisai Corporation Information
    Table 78. Eisai Description and Business Overview
    Table 79. Eisai Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 80. Eisai Product
    Table 81. Eisai Recent Development
    Table 82. Norgine Corporation Information
    Table 83. Norgine Description and Business Overview
    Table 84. Norgine Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 85. Norgine Product
    Table 86. Norgine Recent Development
    Table 87. Arena Pharmaceuticals Corporation Information
    Table 88. Arena Pharmaceuticals Description and Business Overview
    Table 89. Arena Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 90. Arena Pharmaceuticals Product
    Table 91. Arena Pharmaceuticals Recent Development
    Table 92. Orexigen Therapeutics Corporation Information
    Table 93. Orexigen Therapeutics Description and Business Overview
    Table 94. Orexigen Therapeutics Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 95. Orexigen Therapeutics Product
    Table 96. Orexigen Therapeutics Recent Development
    Table 97. Vivus Corporation Information
    Table 98. Vivus Description and Business Overview
    Table 99. Vivus Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 100. Vivus Product
    Table 101. Vivus Recent Development
    Table 102. Alizyme Corporation Information
    Table 103. Alizyme Description and Business Overview
    Table 104. Alizyme Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 105. Alizyme Product
    Table 106. Alizyme Recent Development
    Table 107. Rhythm Pharmaceuticals Corporation Information
    Table 108. Rhythm Pharmaceuticals Description and Business Overview
    Table 109. Rhythm Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 110. Rhythm Pharmaceuticals Product
    Table 111. Rhythm Pharmaceuticals Recent Development
    Table 112. Shionogi Corporation Information
    Table 113. Shionogi Description and Business Overview
    Table 114. Shionogi Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 115. Shionogi Product
    Table 116. Shionogi Recent Development
    Table 117. Zafgan Corporation Information
    Table 118. Zafgan Description and Business Overview
    Table 119. Zafgan Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2017-2022)
    Table 120. Zafgan Product
    Table 121. Zafgan Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Anti Obesity Drugs Customers List
    Table 125. Anti Obesity Drugs Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti Obesity Drugs Product Picture
    Figure 2. Global Anti Obesity Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti Obesity Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Anti Obesity Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Anti Obesity Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Anti Obesity Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Anti Obesity Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Anti Obesity Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Anti Obesity Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Anti Obesity Drugs Report Years Considered
    Figure 11. Product Picture of Oral Medicine
    Figure 12. Product Picture of Diet Patch
    Figure 13. Product Picture of Other
    Figure 14. Global Anti Obesity Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Anti Obesity Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Anti Obesity Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Anti Obesity Drugs Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Anti Obesity Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Anti Obesity Drugs Price by Type (2017-2028) & (USD/Units)
    Figure 20. United States Anti Obesity Drugs Market Share by Type in 2022 & 2028
    Figure 21. United States Anti Obesity Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Anti Obesity Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Anti Obesity Drugs Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Anti Obesity Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Anti Obesity Drugs Price by Type (2017-2028) & (USD/Units)
    Figure 26. Product Picture of Men
    Figure 27. Product Picture of Women
    Figure 28. Global Anti Obesity Drugs Market Share by Application in 2022 & 2028
    Figure 29. Global Anti Obesity Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Anti Obesity Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Anti Obesity Drugs Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Anti Obesity Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Anti Obesity Drugs Price by Application (2017-2028) & (USD/Units)
    Figure 34. United States Anti Obesity Drugs Market Share by Application in 2022 & 2028
    Figure 35. United States Anti Obesity Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Anti Obesity Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Anti Obesity Drugs Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Anti Obesity Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Anti Obesity Drugs Price by Application (2017-2028) & (USD/Units)
    Figure 40. North America Anti Obesity Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Anti Obesity Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Anti Obesity Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Anti Obesity Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Anti Obesity Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Anti Obesity Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. China Taiwan Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Anti Obesity Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Anti Obesity Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Anti Obesity Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Anti Obesity Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Anti Obesity Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Anti Obesity Drugs Value Chain
    Figure 73. Anti Obesity Drugs Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed